Vivoryon Therapeutics Nv Stock Filter Stocks by Fundamentals
VVY Stock | 2.02 0.02 0.98% |
Vivoryon Therapeutics NV fundamentals help investors to digest information that contributes to Vivoryon Therapeutics' financial success or failures. It also enables traders to predict the movement of Vivoryon Stock. The fundamental analysis module provides a way to measure Vivoryon Therapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Vivoryon Therapeutics stock.
Vivoryon |
Did you try this?
Run Competition Analyzer Now
Competition AnalyzerAnalyze and compare many basic indicators for a group of related or unrelated entities |
All Next | Launch Module |
Vivoryon Fundamentals
Return On Equity | -0.67 | |||
Return On Asset | -0.33 | |||
Profit Margin | (1.26) % | |||
Operating Margin | (1.34) % | |||
Current Valuation | 240.95 M | |||
Shares Outstanding | 24.11 M | |||
Shares Owned By Insiders | 33.49 % | |||
Shares Owned By Institutions | 25.10 % | |||
Price To Book | 10.51 X | |||
Price To Sales | 24.14 X | |||
Revenue | 10.76 M | |||
Gross Profit | 9.2 M | |||
EBITDA | (12.03 M) | |||
Net Income | (12.65 M) | |||
Book Value Per Share | 1.15 X | |||
Cash Flow From Operations | (11.26 M) | |||
Earnings Per Share | (0.63) X | |||
Target Price | 43.3 | |||
Number Of Employees | 14 | |||
Beta | 1.7 | |||
Market Capitalization | 365.81 M | |||
Total Asset | 24.52 M | |||
Net Asset | 24.52 M |
About Vivoryon Therapeutics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Vivoryon Therapeutics NV's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Vivoryon Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Vivoryon Therapeutics NV based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Vivoryon Stock Analysis
When running Vivoryon Therapeutics' price analysis, check to measure Vivoryon Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vivoryon Therapeutics is operating at the current time. Most of Vivoryon Therapeutics' value examination focuses on studying past and present price action to predict the probability of Vivoryon Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vivoryon Therapeutics' price. Additionally, you may evaluate how the addition of Vivoryon Therapeutics to your portfolios can decrease your overall portfolio volatility.